Functional impairment of von willebrand factor in hypertrophic cardiomyopathy: Relation to rest and exercise obstruction

Circulation

Volumn 118, Issue 15, 2008, Pages 1550-1557

  Tourneau, Thierry Le ^a,b,d,e   Susen, Sophie ^c,d,e   Caron, Claudine ^c   Millaire, Alain ^a   Maréchaux, Sylvestre ^b,d,e   Polge, Anne Sophie ^b   Vincentelli, André ^d,e   Mouquet, Frederic ^a,d,e   Ennezat, Pierre Vladimir ^a,d,e   Lamblin, Nicolas ^d   De Groote, Pascal ^a   Van Belle, Eric ^a,d,e   Deklunder, Ghislaine ^b   Goudemand, Jenny ^c,d,e   Bauters, Christophe ^a,d   Jude, Brigitte ^c,d,e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Service d'Explorations Fonctionnelles Cardiovasculaires   (France)

^c Institut d'Hématologie Transfusion   (France)

^d INSERM   (France)

^e UNIV LILLE   (France)

Author keywords

Cardiomyopathy; Echocardiography; Exercise; Hypertrophy; Physiology; Von Willebrand factor

Indexed keywords

COLLAGEN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHEAR STRESS; STRESS ECHOCARDIOGRAPHY; THROMBOCYTE ADHESION; VON WILLEBRAND DISEASE; BLOOD; BLOOD CLOTTING DISORDER; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART OUTFLOW TRACT OBSTRUCTION; HEMOSTASIS; HYPERTROPHIC CARDIOMYOPATHY; MECHANICAL STRESS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REST;

ADULT; BLOOD COAGULATION DISORDERS; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; REST; STRESS, MECHANICAL; VENTRICULAR OUTFLOW OBSTRUCTION; VON WILLEBRAND FACTOR;

EID: 55249083933     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.786681     Document Type: Article

References (28)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42:1687-1713.
2. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303.
3. Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1933-1941.
4. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470-476.
5. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239.
6. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.
7. Sadler JE. New concepts in von Willebrand disease. Annu Rev Med. 2005;56:173-191.
8. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171-2179.
9. Warkentin TE, Moore JC, Morgan DG. Gastrointestinal angiodysplasia and aortic stenosis. N Engl J Med. 2002;347:858-859.
10. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet. 1992;340:35-37.
11. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation. 2000;102:1290-1295.
12. Vincentelli A, Susen S, Le Tourneau T, Six I, Fahre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-349.
13. Sadler JE. Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med. 2003;349:323-325.
14. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood. 1998;91:1325-1331.
15. Favaloro EJ, Henniker A, Facey D, Hertzberg M. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor: collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems. Thromb Haemost. 2000;84:541-547.
16. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest. 1980;65:1318-1325.
17. Mazurier C. In vitro evaluation of the haemostatic value of the LFB-von Willebrand factor concentrate. Haemophilia. 1998;4(suppl 3):40-43.
18. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor: cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest. 1986;77:947-951.
19. Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev. 2003;17:272-286.
20. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood. 1986;67:758-761.
21. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84:345-349.
22. Shimizu M, Masai H, Miwa Y. Occult gastrointestinal bleeding due to acquired von Willebrand syndrome in a patient with hypertrophic obstructive cardiomyopathy. Intern Med. 2007;46:481-485.
23. Marechaux S, Ennezat PV, LeJemtel TH, Polge AS, de Groote P, Asseman P, Neviere R, Le Tourneau T, Deklunder G. Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study. Echocardiography. 2007;24:955-959.
24. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation. 1998;97:461-466.
25. Fujita H, Tomiyama J, Chuganji Y, Momoi M, Tanaka T. Diffuse angiodysplasia of the upper gastrointestinal tract in a patient with hypertrophic obstructive cardiomyopathy. Intern Med. 2000;39:385-388.
26. Schwartz J, Rozenfeld V, Habot B. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with, hypertrophic subaortic stenosis: a case history. Angiology. 1992;43:244-248.
27. Alam M, Lewis JW Jr. Cessation of gastrointestinal bleeding from angiodysplasia after surgery for idiopathic hypertrophic subaortic stenosis. Am Heart J. 1991;121:608-610.
28. Riis Hansen P, Hassager C. Septal alcohol ablation and Heyde's syndrome revisited. J Intern Med. 2003;253:490-491.